Allergic protein TBb, a major allergen in tartary buckwheat, was divided into four epitope-containing fragments and was named F1, F2, F3, and F4, respectively. Results of immunological assays revealed that F2 had the strongest IgE-binding activity to patient's sera, which indicated that it might contain the linear IgE-binding epitope of TBb. According to the results of sequence analysis and molecular modeling of tartary buckwheat allergen, three mutants of F2 gene (R139A, R141A, and D144A) were reconstructed using site-directed mutagenesis, and each mutant was expressed in Escherichia coli BL21 (DE3). Following purification by Ni 21 affinity chromatography, enzyme-linked immunosorbent assay and dot blot were performed for wild-type F2 and its mutants using sera from buckwheat-allergic patients and a negative control (non-allergic patient). Results showed that mutants R139A and D144A had weaker IgE-binding activity to patient's sera than wild-type F2, implying that Arg 139 and Asp 144 might be involved in the allergic activity of TBb.
Introduction
Buckwheat belongs to the family Polygonaceae and includes two cultivated species: common buckwheat (CB) (Fagopyrum esculentum) and tartary buckwheat (TB) (Fagopyrum tataricum) [1] . It is reported that the protein content of buckwheat flour is significantly higher than that of rice, wheat, millet, sorghum, and maize. In addition to high-quality protein, buckwheat seeds also contain many bioactive components such as dietary fiber, flavonoids, phytosterols, fagopyrins, and thiamine-binding proteins that have beneficial effects on the cardiovascular health [2, 3] . Thus, it is an important health food, and has been widely studied in terms of planting, breeding, and estimation of nutritional qualities [4] . However, buckwheat can also cause allergy [5] , and results in clinical symptoms including asthma, dermatitis, eczema, and even anaphylactic shock [6] . Since the first buckwheat-allergic patient was reported in 1909, buckwheat has been recognized as one of most important food allergens manifested by severe and dangerous symptoms induced by ingestion or inhalation of a small amount of the flour or food products [7] . The largest study on buckwheat allergy has been performed among 92,680 school children of Yokohama in the 1990s [8] . The prevalence of buckwheat allergy is determined to 0.22% and the incidence of anaphylactic shock due to buckwheat is higher than those due to egg and milk allergy [9] . A series of seven Chinese patients with buckwheat allergy also has been reported in 2010 [10] . These negative effects of buckwheat limit its broad use as an alternative food and popular additive. Therefore, it is urgent to identify allergen molecules for investigating the mechanism of buckwheat allergy.
In the past decades, scientists have reported the allergic composition in CB [11] . Some allergic proteins in CB with different molecular weights of 6, 9, 19, 22, 24, and 60-70 kDa have been identified [12, 13] . With high nutritional and medical values, TB has attracted more attention in recent years. However, reports on allergic composition of TB are limited. Previously, we have obtained several allergic proteins from TB with molecular weight of 24, 34, and 56 kDa, designated TBa, TBb, and TBt, respectively. It has been identified that TBt (a full-length allergic protein in TB) contains cupin fold. This family represents the conserved barrel domain of the Cupin superfamily ('Cupa' is the Latin term for a small barrel), containing 7S and 11S plant seed storage proteins [14] . Each TBt protomer consists of an N-terminal subunit TBb and a C-terminal subunit TBa, which is known to be separated into two peptide chains by post-translational peptidase cleavage. Both TBa and TBb have higher IgE-binding activity than TBt in the detection of immunological activity [15, 16] . We have shown that an epitope called E1 is the major epitope in TBa [17] , but we do not know that about TBb.
In this study, to understand the allergic mechanism of buckwheat foods, we focused on mapping the epitopes of the TB allergic protein TBb and identifying them on a 3D model of the protein.
Materials and Methods

Materials
Thermostable Pfu DNA polymerase was purchased from TIANGEN Biotech (Beijing, China). Taq DNA polymerase was obtained from TaKaRa (Dalian, China). Restriction endonucleases and other enzymes for molecular cloning were purchased from Sangon (Shanghai, China). Horseradishperoxidase (HRP)-conjugated mouse anti-human IgE antibodies were purchased from Southern Biotech (Bimingham, USA).
Sera samples
The sera of three patients ( Table 1 ) with a history of respiratory, dermatologic, or gastrointestinal symptoms occurring within 1 h following ingestion of buckwheat were obtained from the Blood Center of Taiyuan, China. Healthy sera from volunteers not allergic to buckwheat were used as a negative control.
Cloning of epitope-containing fragments in TBb
According to the method of segmental expression, the fulllength allergic protein TBb (298 amino acid residues) was divided into four fragments (Fig. 1) , which were named F1, F2, F3, and F4, respectively. The four epitopecontaining fragments cDNA were polymerase chain reaction (PCR)-amplified from plasmid pET-32m-TBb using the primers listed in Table 2 , and all of their PCR programs were 30 cycles of 948C for 1 min, 608C for 1 min, and 728C for 1 min. PCR products were subcloned into the pGEM-T Easy Vector for sequencing. After being confirmed, the vector was digested with BamHI and HindIII. The fragments obtained were ligated into the expression vector pET-32m to generate four recombinant plasmids ( pET-32m-F1, pET-32m-F2, pET-32m-F3, and pET-32m-F4) [18, 19] .
Sequence analysis and molecular modeling Primary sequences were aligned using BLAST (http://www. ncbi.nlm.nih.gov/BLAST) and displayed with the MegAlign program in the DNAStar software for homologous amino acid residues. Molecular modeling of the TB allergic protein TBt, which contains an N-terminal subunit TBb and a C-terminal subunit TBa, was carried out on a SWISS-MODEL workstation [20] , and displayed with the Cn3D program [21] . The x-ray-solved Cupin structure, available at the Protein Data Bank (PDB) for the almond Pru1 protein (PDB code 3fz3) [22] , shares 60% homology with TBt. Furthermore, TBt had the same cleavage pattern as almond Pru1 protein. Therefore, the almond Pru1 protein could be used as a template to build relatively accurate 3D models of the allergen.
Site-directed mutagenesis of F2
Three mutants with one amino acid replaced by alanine were produced by PCR, using a pair of primers with AGA-to-GCA, AGA-to-GCA, and GAC-to-GCC mutations [23] , respectively ( Table 2 ). The PCR products were then digested and ligated between the BamHI and HindIII multi-cloning sites into the pET-32m expression vector. The mutations in F2 were confirmed by sequence analysis (TaKaRa).
Expression and purification of epitope-containing fragments and mutant fusion proteins
The constructed vectors containing the gene of epitopecontaining fragments or mutants were transformed into Escherichia coli strain BL21 (DE3), and expression of the fusion protein was induced by the addition of isopropyl-b-thiogalacto-pyranoside at a final concentration of 1 mM in LB liquid medium. After 3 h of continuous shaking at 378C, the fusion proteins were purified using a HisTrap affinity purification kit (Amersham Pharmacia Biotech, Uppsala, Sweden). Each recombinant epitopecontaining fragment or mutant was analyzed by means of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using a 12.5% polyacrylamide gel [18, 24] .
Enzyme-linked immunosorbent assay Enzyme-linked immunosorbent assay (ELISA) was performed to detect the IgE-binding activity of epitopecontaining fragments and F2 mutants. After coating 96-well plates with each protein (1.0 mg/50 ml of 50 mM sodium carbonate buffer/well, pH 9.6) and incubating at 48C overnight, the plates were washed with phosphatebuffered saline (PBS, pH 7.5) containing 0.05% Tween 20 (PBS-T), followed by blocking with 1% bovine serum albumin for 1 h at 378C. The plates were then washed with PBS-T, and incubated at 48C overnight with diluted serum samples (1:20) . After further washing using PBS-T, HRP-conjugated mouse anti-human IgE antibodies (Southern Biotech), diluted in PBS-T, were added in wells and incubated for 1 h at 378C, and reacted with chromogen and orthophenylene diamine [23] . The optical density values of the mixture were measured at 490 nm with a microtiter plate reader (Bio-Rad, Hercules, USA). All
ELISAs were performed in triplicate and the data were expressed in mean + SD.
Human IgE dot blot analysis
To test the specific IgE-binding capacity of the recombinant epitope-containing fragments and mutants, an immuno dot-blot assay was performed. Purified proteins were applied to a nitrocellulose membrane and blocked with PBS ( pH 7.5) containing 5% skim milk. Both pooled and individual allergic sera were diluted 1:5 in PBS-T, and incubated with the dot-blots for 1 h at room temperature. Incubation of the membranes with the secondary antibody was performed with a 1:500 dilution of HRP-conjugated mouse anti-human IgE for 1 h. The bound human IgE was detected by incubating with the colorimetric substrate, 3,3 0 -diaminobenzidine (Boster Biotech), and allowing the color signal on the membranes to develop. The membranes were washed extensively with PBS containing 0.1% Tween 20 after each step throughout the protocol.
Statistical analysis
All experiments were conducted in triplicate and the data were expressed in mean + SD. The statistics analysis was performed using SPSS 13.0 software (Chicago, USA) and Microsoft Excel version 5.0 for comparing differences.
Results
Expression, purification, and IgE binding of epitope-containing fragments in TBb Using the method of segmental expression, the vectors containing the genes of four epitope-containing fragments 
The mutated sites are underlined.
Epitope mapping and identification for TBb ( Fig. 1 ) of TBb were constructed successfully. These proteins with 6ÂHis-tagged were expressed and purified according to the manufacturer's instructions (Amersham Pharmacia Biotech). Result of SDS-PAGE showed that the molecular weight was in good agreement with the theoretical prediction [ Fig. 2(A) ], and Ni 2þ affinity chromatography analysis showed that the purity was .98% without significant peaks of impurities.
To determine the IgE reactivity of these epitope-containing fragments and to identify the immunodominant region in TBb, ELISA was performed with each recombinant protein using three IgE-positive sera and a healthy control. As shown in [ Fig. 2(B) ], F2 exhibited the strongest IgE reactivity among all tested epitope-containing fragments (P , 0.05). Additional evaluation of the IgE-binding activity was performed by the dot blot method. As expected, results showed that F2 exhibited the strongest reaction with serum IgE from patients, comparing with other epitope-containing fragments [ Fig. 2(C) ]. Similar results were obtained by using three sera from buckwheat-allergic patients.
Amino acid sequence homology alignment and 3D modeling
The results of amino acid sequence homology alignment showed that the predicted epitope 6 (IFRVREGDV) in fragment 2 (F2) contain identical or structurally homologous amino acids. Furthermore, the surface-exposed regions of the linear IgE-binding epitope 4 (PTRRVRKGD) in Fag13S [25] coincided well with epitope 6 (IFRVREGDV) in TBb (Fig. 3) . The 3D model built for TBt contained Cupin fold. Each protomer consisted of an N-terminal subunit TBb and a C-terminal subunit TBa that are known to be separated into two peptide chains by post-translational peptidase cleavage [ Fig. 4(A,B) ]. Both epitope 6 in TBb and epitope 4 in Fag13S formed a strongly charged area on the molecular surface [ Fig. 4(C,D) ] of the corresponding allergens and exhibited a rather conserved overall conformation characterized by some protruding/charged residues, especially Arg139, Arg141, and Asp144 [ Fig. 4(E,F) ].
Expression and purification of F2 and its mutants
To identify the amino acids in this epitope-containing fragment that is critical for IgE binding, we generated three different wild-type F2 mutants, each with an Arg or Asp replaced by an Ala residue, and referred to them as R139A, R141A, and D144A. These mutants were expressed as 6ÂHis-tagged proteins according to the manufacturer's instructions. The purity was .98% without significant peaks of impurities after affinity chromatography. SDS-PAGE analysis showed that the molecular weight of each mutant was the same as that of wild type F2 [ Fig. 5(A) ].
ELISA assay of binding of WT F2 and its mutants to patient sera F2 and its three mutants were compared for their IgE-binding activity by ELISA, using three serum samples from buckwheat-allergic patients, and one serum sample (non-allergic patient) , and between the four epitope-containing fragments and TBb in their IgE-reactivity were detected by ELISA. Data were expressed in mean + SD (n ¼ 3). (C) Dot blot analysis of epitope-containing fragments. Purified recombinant fusion proteins were applied onto a nitrocellulose membrane. The dot blot was probed with sera from three buckwheat-allergic patients.
Epitope mapping and identification for TBb from a healthy donor as a negative control. As shown in Fig. 5(B) , all three mutants exhibited decreased IgE-binding activity in comparison with WT F2 (P , 0.05), implying that the three charged residues have significant contributions to the IgE binding of the allergen TBb. Among these mutants, R139A and D144A had weaker IgE binding activity (a decrease of nearly 30% from that of the wild type) to patient's sera (P , 0.05), indicating that Arg 139 and Asp 144 might be involved in the allergic activity of TBb. R141A, however, had the weakest IgE-binding activity (a decrease of nearly 50%), suggesting that Arg 141 is more important than Arg 139 and Asp 144 for IgE-binding activity of TBb, and it is the critical amino acid in TBb.
Dot blot analysis of WT F2 and its mutants
To evaluate the IgE reactivity of TBb, epitope-containing fragment F2 and its mutants, purified proteins were applied onto nitrocellulose membranes, and probed with serum samples collected from three allergic individuals. The dot blot results of IgE binding comparing the WT F2 with its three mutants were shown in Fig. 5(C) . It is clear that the substitute mutant R141A showed a weaker signal than R139A and D144A.
Discussion
In this study, the N-terminal subunit TBb was divided into four fragments using the segmental expression method, and the four recombinant epitope-containing fragments were expressed and purified to analyze their immuno-reactivity. The IgE-binding determinant(s) of TBb was mapped with four epitope-containing fragments, and named F1, F2, F3, and F4, respectively. The results of both ELISA and dot blot assays suggested that F2 is likely the immunodominant IgE-binding epitope-containing fragment, and it may contain the linear IgE-binding epitope of TBb. The 3D model built for TB allergen contained three protomers [ Fig. 4(A) ]. Each protomer consisted of an N-terminal subunit TBb and a C-terminal subunit TBa that are known to be separated into two peptide chains by posttranslational peptidase cleavage. Both the TBb and the TBa contained a Cupin fold, and each Cupin structure was connected with a helical region containing three short helixes [ Fig. 4(B) ]. 
Epitope mapping and identification for TBb
Epitope analysis of allergens is a key method to reveal the reason why different allergens cause hypersensitive reactions. Positively charged residues may be needed at these positions for antigen-antibody interaction [26] . Similarly, the four single mutants of Der f 13 allergen (E41A, K3A, K91A, and K103A) have significantly lower IgE-binding reactivity than that of the wild-type Der f 13, and all four residues are charged and exposed on the surface of the protein [27] . Even though some allergens of peanuts and other tree nuts possess a similar Cupin fold, they are different from their IgE-binding epitopes. The different distribution of charged residues (Asp, Glu, Arg, and Lys) on the molecular surface of the allergens is apparently responsible for a rather distinct amino acid sequence, and their overall 3D conformation [28] . Our results of sequence analysis and homology modeling showed that the predicted epitope 6 (IFRVREGDV) in fragment 2 (F2) contains identical or structurally homologous amino acids. Furthermore, the surface-exposed regions of the linear IgE-binding epitope 4 (PTRRVRKGD), which strongly reacted with IgE in Fag13S [25] , coincides well with epitope 6 (IFRVREGDV) in TBb (Fig. 3) . Furthermore, Arg 139 , Arg 141 , and Asp 144 exhibit a rather conserved conformation characterized residues, and form a strongly charged area on the molecular surface [ Fig. 4(E, F) ]. Therefore, we chose Arg 139 , Arg 141 , and Asp 144 to be substituted singly with alanine by site-directed mutagenesis.
Site-directed mutagenesis has been used successfully to produce recombinant forms with low IgE reactivity for some allergens. In this study, the results of ELISA and dot blot demonstrated that, compared with WT F2, all three mutants exhibited decreased IgE-binding activity, implying that the three charged residues have significant contributions to the IgE binding of TBb. Among these mutants, R139A and D144A had weaker IgE-binding activity to patient sera, indicating that Arg 139 and Asp 144 might be involved in the allergic activity of TBb. However, R141A had the weakest IgE-binding activity, suggesting that Arg 141 is more important than Arg 139 and Asp 144 for IgE binding of TBb, and it is likely the critical amino acid in TBb.
In conclusion, a dominant linear IgE epitope-containing fragment of TBb was characterized in this study. We identified fragment 2 (F2) as an immunodominant epitopecontaining fragment. Arg , and Asp 144 are among the critical core amino acid residues of TBb recognized by human IgE antibodies. Based on these results, we believe that modified allergens displaying decreased allergenicity seem to reduce the risk of allergy symptoms, and that our research may provide a clue to treat TB allergy. Furthermore, application of our experiments may contribute to the development of a transgenic hypoallergenic crop.
